Log In
BCIQ
Print this Print this
 

GLB333

  Manage Alerts
Collapse Summary General Information
Company Globe Laboratories Inc.
DescriptionUndisclosed cytokine inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationWounds
Indication DetailsTreat wound healing in diabetics
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/07/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today